Display options
Cite
Luo X, Huang L, Han L, et al. Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. Schizophr Bull. 2014;40(6):1285-99doi: 10.1093/schbul/sbu045.
Luo, X., Huang, L., Han, L., Luo, Z., Hu, F., Tieu, R., & Gan, L. (2014). Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. Schizophrenia bulletin, 40(6), 1285-99. https://doi.org/10.1093/schbul/sbu045
Luo, Xiongjian, et al. "Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes." Schizophrenia bulletin vol. 40,6 (2014): 1285-99. doi: https://doi.org/10.1093/schbul/sbu045
Luo X, Huang L, Han L, Luo Z, Hu F, Tieu R, Gan L. Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes. Schizophr Bull. 2014 Nov;40(6):1285-99. doi: 10.1093/schbul/sbu045. Epub 2014 Mar 24. PMID: 24664977; PMCID: PMC4193716.
Copy Download .nbib Format: NLM
Share it on

Schizophr Bull. 2014 Nov;40(6):1285-99. doi: 10.1093/schbul/sbu045. Epub 2014 Mar 24.

Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes.

Schizophrenia bulletin

Xiongjian Luo, Liang Huang, Leng Han, Zhenwu Luo, Fang Hu, Roger Tieu, Lin Gan

Affiliations

  1. Flaum Eye Institute and Department of Ophthalmology, University of Rochester, Rochester, NY; College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China; State Key Laboratory of Genetic Engineering and Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China; [email protected].
  2. First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China; Affiliated Eye Hospital of Nanchang University, Nanchang, Jiangxi, China;
  3. Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX;
  4. Wuhan Institute of Virology, Chinese Academy of Sciences, WuChang, Wuhan, China;
  5. Department of Biochemistry, Emory University, Atlanta, GA.
  6. Flaum Eye Institute and Department of Ophthalmology, University of Rochester, Rochester, NY; College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China;

PMID: 24664977 PMCID: PMC4193716 DOI: 10.1093/schbul/sbu045

Abstract

Schizophrenia is a common mental disorder with high heritability and strong genetic heterogeneity. Common disease-common variants hypothesis predicts that schizophrenia is attributable in part to common genetic variants. However, recent studies have clearly demonstrated that copy number variations (CNVs) also play pivotal roles in schizophrenia susceptibility and explain a proportion of missing heritability. Though numerous CNVs have been identified, many of the regions affected by CNVs show poor overlapping among different studies, and it is not known whether the genes disrupted by CNVs contribute to the risk of schizophrenia. By using cumulative scoring, we systematically prioritized the genes affected by CNVs in schizophrenia. We identified 8 top genes that are frequently disrupted by CNVs, including NRXN1, CHRNA7, BCL9, CYFIP1, GJA8, NDE1, SNAP29, and GJA5. Integration of genes affected by CNVs with known schizophrenia susceptibility genes (from previous genetic linkage and association studies) reveals that many genes disrupted by CNVs are also associated with schizophrenia. Further protein-protein interaction (PPI) analysis indicates that protein products of genes affected by CNVs frequently interact with known schizophrenia-associated proteins. Finally, systematic integration of CNVs prioritization data with genetic association and PPI data identifies key schizophrenia candidate genes. Our results provide a global overview of genes impacted by CNVs in schizophrenia and reveal a densely interconnected molecular network of de novo CNVs in schizophrenia. Though the prioritized top genes represent promising schizophrenia risk genes, further work with different prioritization methods and independent samples is needed to confirm these findings. Nevertheless, the identified key candidate genes may have important roles in the pathogenesis of schizophrenia, and further functional characterization of these genes may provide pivotal targets for future therapeutics and diagnostics.

© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: [email protected].

Keywords: CHRNA7; NRXN1; copy number variation; integrative analysis; prioritization; schizophrenia

References

  1. Nat Med. 2006 Jul;12(7):824-8 - PubMed
  2. Schizophr Res. 2005 Oct 15;78(2-3):339-41 - PubMed
  3. Hum Genet. 2011 Oct;130(4):563-73 - PubMed
  4. Genome Res. 2003 Nov;13(11):2498-504 - PubMed
  5. Nat Rev Neurosci. 2010 Jun;11(6):402-16 - PubMed
  6. Nat Biotechnol. 2007 Mar;25(3):309-16 - PubMed
  7. Mol Psychiatry. 2013 Jun;18(6):708-12 - PubMed
  8. Lancet. 2007 Oct 20;370(9596):1443-52 - PubMed
  9. Nature. 2011 Mar 24;471(7339):499-503 - PubMed
  10. Hum Mol Genet. 2008 Feb 1;17(3):458-65 - PubMed
  11. Nature. 2008 Sep 11;455(7210):237-41 - PubMed
  12. Mol Psychiatry. 2002;7(4):405-11 - PubMed
  13. Schizophr Res. 2012 Sep;140(1-3):185-91 - PubMed
  14. Nature. 2009 Aug 6;460(7256):744-7 - PubMed
  15. Biol Psychiatry. 2010 Feb 1;67(3):283-6 - PubMed
  16. Arch Gen Psychiatry. 2011 Mar;68(3):232-40 - PubMed
  17. Schizophr Bull. 2014 Jan;40(1):39-49 - PubMed
  18. Am J Hum Genet. 2003 Jul;73(1):34-48 - PubMed
  19. Nat Genet. 2013 Oct;45(10):1150-9 - PubMed
  20. Hum Mol Genet. 2011 Oct 15;20(20):4076-81 - PubMed
  21. Am J Med Genet B Neuropsychiatr Genet. 2006 Mar 5;141B(2):142-8 - PubMed
  22. Mol Psychiatry. 2009 Mar;14(3):252-60 - PubMed
  23. BMC Genomics. 2012;13 Suppl 8:S2 - PubMed
  24. Nat Protoc. 2009;4(1):44-57 - PubMed
  25. Neuron. 2013 Sep 18;79(6):1169-82 - PubMed
  26. Schizophr Res. 2006 Dec;88(1-3):235-44 - PubMed
  27. Nat Biotechnol. 2006 May;24(5):537-44 - PubMed
  28. Am J Med Genet. 2001 Jan 8;105(1):20-2 - PubMed
  29. Am J Hum Genet. 2001 Aug;69(2):428-33 - PubMed
  30. Arch Gen Psychiatry. 1999 Oct;56(10):940-5 - PubMed
  31. Hum Genet. 2014 Feb;133(2):125-38 - PubMed
  32. Nat Rev Genet. 2012 Jul 03;13(8):523-36 - PubMed
  33. Am J Psychiatry. 2011 Mar;168(3):302-16 - PubMed
  34. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20870-5 - PubMed
  35. Nat Genet. 2011 Sep 18;43(10):969-76 - PubMed
  36. Am J Med Genet. 2001 Dec 8;105(8):669-74 - PubMed
  37. Neurosci Lett. 2010 Sep 6;481(2):120-5 - PubMed
  38. J Biol Chem. 2005 Apr 29;280(17):17312-9 - PubMed
  39. Schizophr Bull. 2009 Sep;35(5):851-4 - PubMed
  40. Hum Mol Genet. 2002 Oct 1;11(20):2417-23 - PubMed
  41. Mol Psychiatry. 2012 Sep;17(9):887-905 - PubMed
  42. Mol Psychiatry. 2009 Aug;14(8):774-85 - PubMed
  43. Bioinformatics. 2009 Oct 1;25(19):2595-6602 - PubMed
  44. Nat Genet. 2008 Jul;40(7):880-5 - PubMed
  45. Curr Opin Neurobiol. 2007 Feb;17(1):43-52 - PubMed
  46. Am J Hum Genet. 2010 Jul 9;87(1):139-45 - PubMed
  47. PLoS Med. 2005 May;2(5):e141 - PubMed
  48. PLoS Genet. 2011 Jan 13;7(1):e1001273 - PubMed
  49. Nat Genet. 2011 Oct 30;43(12):1224-7 - PubMed
  50. BMC Cancer. 2008 Jul 15;8:199 - PubMed
  51. Arch Gen Psychiatry. 2003 Dec;60(12):1187-92 - PubMed
  52. Am J Med Genet. 2000 Apr 3;96(2):196-201 - PubMed
  53. Cell. 2013 Aug 1;154(3):518-29 - PubMed
  54. Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):96-101 - PubMed
  55. Mol Psychiatry. 2001 Mar;6(2):193-201 - PubMed
  56. Mol Psychiatry. 2005 Apr;10(4):353-65 - PubMed
  57. Hum Mol Genet. 2014 May 15;23(10):2780-90 - PubMed
  58. Am J Psychiatry. 2011 Mar;168(3):253-6 - PubMed
  59. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6917-22 - PubMed
  60. Schizophr Res. 2010 Jul;120(1-3):131-42 - PubMed
  61. Nucleic Acids Res. 2009 Jan;37(1):1-13 - PubMed
  62. Am J Psychiatry. 2010 Aug;167(8):899-914 - PubMed
  63. Science. 2005 Nov 18;310(5751):1187-91 - PubMed
  64. Mol Psychiatry. 2012 Feb;17(2):142-53 - PubMed
  65. Nature. 2009 Aug 6;460(7256):748-52 - PubMed
  66. Biol Psychiatry. 2013 May 15;73(10):951-66 - PubMed
  67. Mol Psychiatry. 2002;7(5):446-7 - PubMed
  68. Nature. 2008 Oct 16;455(7215):903-11 - PubMed
  69. Schizophr Bull. 1993;19(2):261-85 - PubMed
  70. Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W377-84 - PubMed
  71. Nat Genet. 2008 Jul;40(7):827-34 - PubMed
  72. Mol Psychiatry. 2011 Apr;16(4):362-4 - PubMed
  73. Mol Psychiatry. 2012 Sep;17(9):906-17 - PubMed
  74. Schizophr Res. 2013 Feb;143(2-3):390-2 - PubMed
  75. Am J Psychiatry. 2003 Mar;160(3):469-76 - PubMed
  76. Mol Psychiatry. 2013 Feb;18(2):206-14 - PubMed
  77. Nat Genet. 2008 Sep;40(9):1053-5 - PubMed
  78. Nature. 2008 Sep 11;455(7210):232-6 - PubMed
  79. Behav Brain Funct. 2011 Apr 11;7:7 - PubMed
  80. Nat Genet. 2011 Oct 30;43(12):1228-31 - PubMed
  81. Clin Genet. 2007 Jan;71(1):1-11 - PubMed
  82. PLoS Genet. 2009 Jan;5(1):e1000351 - PubMed
  83. Nat Genet. 2009 Nov;41(11):1223-7 - PubMed
  84. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10584-9 - PubMed
  85. Hum Mol Genet. 2000 May 22;9(9):1415-23 - PubMed
  86. Mol Psychiatry. 2010 May;15(5):453-62 - PubMed
  87. Br J Psychiatry. 2007 Mar;190:194-9 - PubMed
  88. Mol Psychiatry. 2006 Dec;11(12):1062-5 - PubMed
  89. Blood. 2010 Jul 1;115(26):5376-84 - PubMed
  90. J Med Genet. 2006 Aug;43(8):691-8 - PubMed
  91. Am J Hum Genet. 2002 Dec;71(6):1296-302 - PubMed

MeSH terms

Publication Types